Aldosterone induces oxidative stress, oxidative DNA damage and NF-κB-activation in kidney tubule cells

✍ Scribed by Nina Queisser; Patricia I. Oteiza; Helga Stopper; Rajaraman G. Oli; Nicole Schupp

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 436 KB
• Volume: 50
• Category: Article
• ISSN: 0899-1987
• DOI: 10.1002/mc.20710

✦ Synopsis

An increase of the mineralocorticoid aldosterone is induced by a stimulated renin-angiotensin system in a subgroup of hypertensive patients. Epidemiological studies find higher cancer mortality in hypertensive patients and an increased risk to develop kidney cancer. This work investigated the involvement of oxidants in the genotoxicity of aldosterone and on a potential activation of transcription factor nuclear factor-kB (NF-kB) in kidney tubule cells. Aldosterone, at concentrations as low as 1 nM caused a significant increase of DNA damage, as assessed by comet assay and micronucleus frequency test. Aldosterone also led to a dose-dependent activation of NF-kB. Time courses of DNA damage and NF-kB-activation showed that these effects already occurred after 5 and 30 min of aldosterone exposure, respectively, suggesting non-genomic events of the hormone. Antioxidants prevented aldosterone-induced DNA damage and NF-kB-activation, indicating the involvement of oxidants. In fact, aldosterone caused an increase in intracellular oxidant levels, and in particular of superoxide anions. As a consequence, increased levels of the oxidized DNA modification 7,8-dihydro-8-oxo-guanine were observed in aldosterone-treated kidney cells. Aldosterone-induced DNA damage and NF-kB-activation was dependent on the involvement of the mineralocorticoid receptor. The induction of oxidant-mediated genotoxic effects, and of a long-term activation of the potentially oncogenic cell signal NF-kB by aldosterone could contribute to the increased kidney cancer incidence in hypertensive patients.